catechin has been researched along with cardiovascular agents in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.88) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 4 (23.53) | 29.6817 |
| 2010's | 11 (64.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bastide, J; Bastide, P; Gross, D; Pourrat, A; Pourrat, H; Vennat, B | 1 |
| Aldini, G; Berti, F; Bombardelli, E; Carini, M; Maffei Facinó, R; Morazzoni, P; Rossoni, G | 1 |
| Catapano, AL; Marchesi, P; Norata, GD; Passamonti, S; Pirillo, A; Violi, F | 1 |
| Babu, PV; Sabitha, KE; Shyamaladevi, CS; Srinivasan, P | 1 |
| Devika, PT; Prince, PS | 1 |
| Barraza-Hidalgo, M; Ceballos, G; Cortez-Gomez, B; Cruz, M; Rivas, M; Romero-Perez, D; Villarreal, F; Yamazaki, KG | 1 |
| Fujii, H; Hattori, Y; Hayashi, T; Matsuda, N; Nishioka, H; Yokoo, H; Zhang, XH | 1 |
| Czernizer, E; Dardik, A; Dardik, H; Hoffmann, T; London, D; Naftalovich, R; Orozco-Sevilla, V; Yang, C | 1 |
| Nie, S; Wang, S; Zhang, J | 1 |
| Chakraborti, S; Chakraborti, T; Chowdhury, A; Sarkar, J | 1 |
| Kochi, T; Sakai, H; Seishima, M; Shimizu, M; Shirakami, Y | 1 |
| Fumoto, T; Imaizumi, T; Masumoto, S; Matsuda, N; Miura, T; Naraoka, M; Ohkuma, H; Shoji, T; Wang, L | 1 |
| Eng, QY; Ramamurthy, S; Thanikachalam, PV | 1 |
| Cao, K; Chen, H; Fan, X; Min, X; Tu, S; Xiao, F | 1 |
| Ayala-Hernandez, M; Bustamante, M; Castillo, C; Ceballos, G; Guevara, G; Loredo, M; Mansour, C; Navarrete-Yañez, V; Ramirez-Sanchez, I; Villarreal, FJ | 1 |
| Gan, Y; Liu, J; Liu, L; Tian, J; Zhao, W | 1 |
| Isemura, M | 1 |
2 review(s) available for catechin and cardiovascular agents
| Article | Year |
|---|---|
Catechins and Its Role in Chronic Diseases.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cardiovascular Agents; Catechin; Chronic Disease; Disease Models, Animal; Drug Discovery; Humans; Molecular Structure; Neuroprotective Agents; Phytotherapy; Plant Extracts; Plants, Medicinal; Signal Transduction; Structure-Activity Relationship; Tea | 2016 |
Molecular understanding of Epigallocatechin gallate (EGCG) in cardiovascular and metabolic diseases.
Topics: Animals; Anti-Inflammatory Agents; Camellia sinensis; Cardiovascular Agents; Cardiovascular Diseases; Catechin; Humans; Metabolic Diseases; Tea | 2018 |
15 other study(ies) available for catechin and cardiovascular agents
| Article | Year |
|---|---|
Procyanidins from the roots of Fragaria vesca: characterization and pharmacological approach.
Topics: Animals; Biflavonoids; Cardiovascular Agents; Catechin; Chromatography, High Pressure Liquid; Male; Plants, Medicinal; Proanthocyanidins; Rats; Rats, Inbred Strains | 1988 |
Procyanidines from Vitis vinifera seeds protect rabbit heart from ischemia/reperfusion injury: antioxidant intervention and/or iron and copper sequestering ability.
Topics: Animals; Antioxidants; Biflavonoids; Cardiovascular Agents; Catechin; Copper; Epoprostenol; Free Radical Scavengers; Fruit; Heart; Iron; Male; Myocardial Reperfusion Injury; Proanthocyanidins; Rabbits; Seeds | 1996 |
Anti-inflammatory and anti-atherogenic effects of cathechin, caffeic acid and trans-resveratrol in apolipoprotein E deficient mice.
Topics: Animals; Anti-Inflammatory Agents; Aorta; Apolipoproteins E; Atherosclerosis; Caffeic Acids; Cardiovascular Agents; Catechin; Cytokines; Dietary Fats; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelin-1; Gene Expression; Mice; Mice, Knockout; Receptors, Chemokine; RNA, Messenger; Stilbenes | 2007 |
Green tea attenuates diabetes induced Maillard-type fluorescence and collagen cross-linking in the heart of streptozotocin diabetic rats.
Topics: Animals; Aspartate Aminotransferases; Blood Glucose; Blood Pressure; Caffeine; Camellia sinensis; Cardiovascular Agents; Catechin; Collagen; Creatine Kinase; Diabetes Mellitus, Experimental; Fibrosis; Glycated Hemoglobin; Glycation End Products, Advanced; Glycosylation; Heart Diseases; Hypoglycemic Agents; L-Lactate Dehydrogenase; Maillard Reaction; Male; Myocardium; Plant Extracts; Plant Leaves; Protein Processing, Post-Translational; Rats; Rats, Wistar; Solubility; Spectrometry, Fluorescence | 2007 |
Preventive effect of (-)epigallocatechin-gallate (EGCG) on lysosomal enzymes in heart and subcellular fractions in isoproterenol-induced myocardial infarcted Wistar rats.
Topics: Animals; Cardiovascular Agents; Catechin; Disease Models, Animal; Heart; Isoproterenol; Lysosomes; Male; Myocardial Infarction; Rats; Rats, Wistar; Subcellular Fractions; Time Factors | 2008 |
Short- and long-term effects of (-)-epicatechin on myocardial ischemia-reperfusion injury.
Topics: Administration, Oral; Animals; Cardiovascular Agents; Catechin; Disease Models, Animal; Drug Administration Schedule; Hemodynamics; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Oxidative Stress; Peroxidase; Rats; Rats, Sprague-Dawley; Time Factors | 2008 |
Beneficial effect of the oligomerized polyphenol oligonol on high glucose-induced changes in eNOS phosphorylation and dephosphorylation in endothelial cells.
Topics: Animals; Bradykinin; Cardiovascular Agents; Catechin; Cells, Cultured; Dose-Response Relationship, Drug; Endothelial Cells; Glucose; Nitric Oxide; Nitric Oxide Synthase Type III; p38 Mitogen-Activated Protein Kinases; Phenols; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Kinase C-epsilon; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Serine; Signal Transduction; Superoxide Dismutase; Swine; Threonine; Time Factors | 2010 |
Epigallocatechin-3-gallate is a potent phytochemical inhibitor of intimal hyperplasia in the wire-injured carotid artery.
Topics: Animals; Cardiovascular Agents; Carotid Artery Injuries; Carotid Artery, Common; Carotid Intima-Media Thickness; Catechin; Cell Proliferation; Disease Models, Animal; Disulfides; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Hyperplasia; Injections, Intraperitoneal; Isothiocyanates; Male; Neointima; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Sulfinic Acids; Sulfoxides; Time Factors | 2013 |
Nanoencapsulation enhances epigallocatechin-3-gallate stability and its antiatherogenic bioactivities in macrophages.
Topics: Atherosclerosis; Camellia sinensis; Cardiovascular Agents; Catechin; Cell Line; Chemokine CCL2; Cholesterol; Drug Compounding; Drug Stability; Humans; Macrophages; Nanoparticles; Plant Extracts | 2013 |
Role of Spm-Cer-S1P signalling pathway in MMP-2 mediated U46619-induced proliferation of pulmonary artery smooth muscle cells: protective role of epigallocatechin-3-gallate.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Cardiovascular Agents; Cardiovascular Diseases; Catechin; Cattle; Cell Culture Techniques; Cell Proliferation; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; Myocytes, Smooth Muscle; Pulmonary Artery; Vasoconstrictor Agents | 2015 |
Regression of atherosclerosis with apple procyanidins by activating the ATP-binding cassette subfamily A member 1 in a rabbit model.
Topics: Animals; Aorta; Aortic Diseases; Atherosclerosis; ATP Binding Cassette Transporter 1; Biflavonoids; Cardiovascular Agents; Catechin; Cholesterol; Disease Models, Animal; Fruit; Lipoproteins, LDL; Male; Malus; Oxidative Stress; Phytotherapy; Plants, Medicinal; Plaque, Atherosclerotic; Proanthocyanidins; Reactive Oxygen Species; RNA, Messenger; Scavenger Receptors, Class E; Time Factors; Up-Regulation | 2017 |
Catechin Attenuates Coronary Heart Disease in a Rat Model by Inhibiting Inflammation.
Topics: Animals; Anti-Inflammatory Agents; Biomarkers; Blood Glucose; Cardiovascular Agents; Catechin; Coronary Disease; Cytokines; Disease Models, Animal; Inflammation Mediators; Lipids; Myocytes, Cardiac; Rats, Wistar; Signal Transduction; Stroke Volume; Ventricular Function, Left | 2018 |
(-)-Epicatechin induced reversal of endothelial cell aging and improved vascular function: underlying mechanisms.
Topics: Acetylation; Aging; Animals; Antioxidants; Aorta, Thoracic; Biomarkers; Cardiovascular Agents; Catechin; Cattle; Cells, Cultured; Cellular Senescence; Coronary Vessels; Dietary Supplements; Endothelium, Vascular; Male; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphorylation; Protein Processing, Post-Translational; Rats, Wistar; Sirtuin 1; Vascular Diseases | 2018 |
Epigallocatechin-3 gallate prevents pressure overload-induced heart failure by up-regulating SERCA2a via histone acetylation modification in mice.
Topics: Acetylation; Animals; Aortic Diseases; Cardiovascular Agents; Catechin; Constriction, Pathologic; Disease Models, Animal; Heart Failure; Histone Deacetylase 1; Histones; Male; Mice, Inbred C57BL; Promoter Regions, Genetic; Protective Agents; Random Allocation; RNA, Messenger; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Up-Regulation | 2018 |
Catechin in Human Health and Disease.
Topics: Anti-Infective Agents; Anti-Obesity Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Camellia sinensis; Cardiovascular Agents; Catechin; Humans; Hypoglycemic Agents; Isomerism; Neuroprotective Agents; Tea | 2019 |